Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Emeis (EMEIS.PA)
Puteaux, FR
Emeis Société anonyme operates as a prominent provider of diverse healthcare services, encompassing the management of nursing homes, assisted-living facilities, specialized post-acute and rehabilitation hospitals, and psychiatric treatment centers. Within its elderly care residences, the company delivers tailored support alongside comprehensive logistical and residential amenities, including comfortable accommodation, meal services, laundry, and room maintenance. These facilities also enrich residents' lives with a variety of daily events, recreational activities, and therapeutic workshops. Emeis's post-acute and rehabilitation hospitals are equipped to treat a wide array of medical conditions, such as geriatric issues, musculoskeletal and neurological disorders, cardiovascular and hematological ailments, oncology recovery, and care for individuals in persistent vegetative or minimally conscious states. The psychiatric hospitals address an extensive spectrum of mental health concerns, ranging from mood, anxiety, and obsessive-compulsive disorders to addictions, eating disorders, sleep disturbances, personality disorders, age-related psychiatric conditions, psychosis, and stress-induced conditions like burnout, chronic fatigue syndrome, fibromyalgia, psychosomatic issues, and post-traumatic stress disorder. Furthermore, they offer specialized psychiatric care for geriatrics, children, young adults, and parent-child dynamics, serving both public and private patients. Complementing its institutional offerings, Emeis also provides comprehensive home care solutions. These include practical domestic assistance such as cleaning, meal preparation, ironing, gardening, and running errands; daily living support encompassing day or night supervision and aid with hygiene and meals; and mobility assistance. Founded in 1989 and headquartered in Puteaux, France, the company maintains an expansive international presence, with operations spanning numerous countries across Europe, Latin America, and Asia, including France, Belgium, Spain, Italy, Ireland, Switzerland, Austria, Germany, the Czech Republic, Poland, the Netherlands, Luxembourg, Portugal, Brazil, Russia, Slovenia, Uruguay, Colombia, Mexico, Chile, Latvia, Croatia, and China.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +1.36% | +1.94% | -3.87% | +1.72% | +8.92% | -1.12% | +35.08% | -87.49% | -99.79% | -99.69% | -96.70% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-06 | Change |
|---|---|---|
| Strong Buy | 0 | -1 |
| Buy | 2 | 0 |
| Hold | 3 | 0 |
| Sell | 0 | -2 |
| Strong Sell | 0 | 0 |
-
Revenue growth Medical - Care Facilities: +10.2%+4.6% Q4'25: +67.1% (vs Q4'23)
-
EPS growth Medical - Care Facilities: +19.2%+29.4% ★ Q4'25: -109.4% (vs Q4'23)
-
FCF margin FCF growth · Medical - Care Facilities: +32.0%+2.9% ★ Q4'25: +10.7% (vs Q4'23)
-
EBIT margin Medical - Care Facilities: +11.3%+1.4% Q4'25: +0.6% (vs Q4'23)
-
ROIC Medical - Care Facilities: +6.8%+0.8% Q4'25: +1.2% (vs Q4'23)
-
Share dilution Medical - Care Facilities: +0.0%+2.4% Q4'25: +40.9% (vs Q4'23)
-
Debt / EBITDA Net debt/EBITDA · Medical - Care Facilities: 0.99×11.62× Q4'25: 4.11× (vs Q4'23)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 6 Rev. Ana. 2 EPS Ana. |
Dec 2027 6 Rev. Ana. 2 EPS Ana. |
Dec 2028 5 Rev. Ana. 4 EPS Ana. |
|---|---|---|---|---|---|---|
| Revenue |
5.20B
est: 5.43B (-4.3%)
|
5.64B
est: 5.77B (-2.4%)
|
5.90B
est: 5.93B (-0.6%)
|
6.08B
5.63B – 6.25B
+2.5% YoY
|
6.31B
5.88B – 6.55B
+3.7% YoY
|
6.55B
6.09B – 6.77B
+3.9% YoY
|
| EBITDA |
2.80B
est: 225.34M (+1,143.7%)
|
731.55M
est: 239.53M (+205.4%)
|
740.25M
est: 246.08M (+200.8%)
|
252.27M
233.75M – 259.16M
+2.5% YoY
|
261.71M
243.88M – 271.81M
+3.7% YoY
|
271.89M
252.66M – 280.87M
+3.9% YoY
|
| EBIT |
1.98B
est: -421.80M (+569.9%)
|
38.90M
est: -448.37M (+108.7%)
|
80.14M
est: -460.62M (+117.4%)
|
-472.22M
-485.11M – -437.55M
-2.5% YoY
|
-489.89M
-508.79M – -456.51M
-3.7% YoY
|
-508.94M
-525.75M – -472.94M
-3.9% YoY
|
| Net Income |
1.35B
est: 2.69B (-49.7%)
|
-412.07M
est: -292.47M (-40.9%)
|
-298.40M
est: -178.82M (-66.9%)
|
-62.86M
-67.21M – -58.52M
+64.8% YoY
|
33.00M
30.72M – 35.28M
+152.5% YoY
|
30.79M
-32.48M – 114.38M
-6.7% YoY
|
| SGA |
—
|
—
|
—
|
—
— – —
|
—
— – —
|
—
— – —
|
| EPS |
11.85
est: 17.13 (-30.8%)
|
-2.62
est: -1.80 (-45.6%)
|
-1.85
est: -1.06 (-74.6%)
|
-0.40
-0.42 – -0.36
+62.2% YoY
|
0.21
0.19 – 0.22
+152.5% YoY
|
0.18
-0.20 – 0.71
-13.3% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-06-12 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-06-11 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-06-10 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-06-09 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-06-08 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-06-05 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-06-04 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-06-03 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-06-02 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-06-01 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-29 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-28 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-27 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-26 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-25 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-22 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-21 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-20 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-19 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-18 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-15 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-14 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-13 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-12 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-11 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-08 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-07 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-06 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-05 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-04 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-30 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-29 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-28 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-27 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-24 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-23 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-22 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-21 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-20 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-17 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-16 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | State Street SPDR MSCI Europe Small Cap Value Weighted UCITS ETF EUR Acc ZPRX.DE | 0.35% | 2.68M | 0.30% |
| 2 | Global X - Aging Population ETF AGNG | 0.29% | 251.9K | 0.50% |
| 3 | UBS MSCI EMU Small Cap UCITS ETF EUR dis UEFD.DE | 0.19% | 1.44M | 0.33% |
| 4 | iShares MSCI EMU Small Cap UCITS ETF CES1.L | 0.19% | 2.01M | 0.58% |
| 5 | Avantis International Small Cap Value ETF AVDV | 0.13% | 24.04M | 0.36% |
| 6 | iShares Ageing Population UCITS ETF AGED.L | 0.11% | 969.5K | 0.40% |
| 7 | iShares MSCI Europe Small-Cap ETF IEUS | 0.08% | 132.0K | 0.41% |
| 8 | Xtrackers MSCI Europe Small Cap UCITS ETF 1C XXSC.L | 0.07% | 2.55M | 0.30% |
| 9 | Schwab International Small-Cap Equity ETF SCHC | 0.05% | 2.78M | 0.06% |
| 10 | Dimensional - International Small Cap ETF DFIS | 0.04% | 2.41M | 0.39% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Laurent Guillot | CEO, MD of France & Director | 2M | male |
| Asuncion Zaragoza | Managing Director of Spain & Portugal | — | female |
| Beata Leszczynska | Managing Director of Poland | — | — |
| Berengere Demoulin | Group Legal Affairs Director | — | — |
| Fanny Barbier | Group Human Resources Director | — | female |
| Frederique Raoult | Group Communications Director | — | female |
| Guillaume Dunis | Director of Internal Control, Audit, Risk, Compliance & Group Insurance | — | male |
| Jean-Marc Boursier | Group Chief Financial Officer | — | male |
| Anton Kellner | Managing Director Central and Eastern Europe | — | male |
| Leonard Addesso | Executive Vice President of Construction | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for EMEIS.PA
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
